The above results suggest that USP11 not only promotes or inhibits colorectal cancer, but also mediates chemotherapy resistance in colorectal cancer, and targeting USP11 may be an effective therapeutic strategy for colorectal cancer patients (Fig. 3). The gene discussed is USP11; the disease is colorectal cancer.